Document is current

Any future updates will be listed below

The high need for trials assessing functional outcome after stroke rather than stroke prevention with GLP-1 agonists and DPP-4 inhibitors

Crossref DOI link: https://doi.org/10.1186/s12933-018-0674-3

Published Online: 2018-02-21

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark